← All indications
Albuminuria
The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
Drugs by status
Phase 4 trials (22)
Phase 3 trials (9)
Phase 2 trials (9)
Organizations
Organization Involved with Phase 4 Indications (25)
- Bristol-Myers Squibb
- Astellas
- AstraZeneca
- Novo Nordisk
- Sanofi
- Novartis
- Effice Servicios Para la Investigacion S.L.
- Sponsor GmbH
- TSH Biopharm Corporation Limited
- Fundación Renal Iñigo Alvarez De Toledo
- Nanjing Medical University
- Shiga University
- University of Groningen
- University of Tehran
- University of Toronto
- Capital Medical University
- Taichung Veterans General Hospital
- Xiamen University
- University of Copenhagen
- Rush University
- Sun Yat-Sen University
- State University of New York, Buffalo
- University of New South Wales
- Johnson and Johnson
- Steno Diabetes Center Copenhagen
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (27)
- AbbVie
- Biomarin
- Addmedica
- Ironwood Pharmaceuticals
- Exelixis
- Pfizer
- Ardelyx
- ChemoCentryx
- Speedel Pharma Ltd.
- Genkyotex Innovation SAS
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Aminu Kano Teaching Hospital
- Radboud University
- University of Michigan
- Vanderbilt University
- University of Campinas
- CHU Henri Mondor
- Mitsubishi Tanabe
- Noxxon AG
- University of North Carolina at Chapel Hill
- University of Alabama, Birmingham
- Sungkyunkwan University
- Symphony Capital
- SRL Medisearch
Organization Involved with Other Experimental Indications (5)